NO303637B1 - 7-disubstituert-metyl-4-okso-3H,5H-pyrrolo-£3,2-d|pyrimidin, farmas°ytisk preparat, og anvendelse derav - Google Patents
7-disubstituert-metyl-4-okso-3H,5H-pyrrolo-£3,2-d|pyrimidin, farmas°ytisk preparat, og anvendelse deravInfo
- Publication number
- NO303637B1 NO303637B1 NO943988A NO943988A NO303637B1 NO 303637 B1 NO303637 B1 NO 303637B1 NO 943988 A NO943988 A NO 943988A NO 943988 A NO943988 A NO 943988A NO 303637 B1 NO303637 B1 NO 303637B1
- Authority
- NO
- Norway
- Prior art keywords
- dipyrimidine
- pyrrolo
- disubstituted
- oxo
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/35—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/40—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87144192A | 1992-04-21 | 1992-04-21 | |
| PCT/US1993/002841 WO1993021187A1 (en) | 1992-04-21 | 1993-03-25 | 7-DISUBSTITUTED-METHYL-4-OXO-3H^_,5H^_-PYRROLO[3,2-d^_]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO943988L NO943988L (no) | 1994-10-20 |
| NO943988D0 NO943988D0 (no) | 1994-10-20 |
| NO303637B1 true NO303637B1 (no) | 1998-08-10 |
Family
ID=25357439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO943988A NO303637B1 (no) | 1992-04-21 | 1994-10-20 | 7-disubstituert-metyl-4-okso-3H,5H-pyrrolo-£3,2-d|pyrimidin, farmas°ytisk preparat, og anvendelse derav |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0638080A4 (no) |
| JP (1) | JPH07507062A (no) |
| KR (1) | KR950701335A (no) |
| AU (1) | AU4276693A (no) |
| CA (1) | CA2133346A1 (no) |
| FI (1) | FI944933A0 (no) |
| HU (1) | HUT71559A (no) |
| NO (1) | NO303637B1 (no) |
| RU (1) | RU94046387A (no) |
| WO (1) | WO1993021187A1 (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19709877A1 (de) * | 1997-03-11 | 1998-09-17 | Bayer Ag | 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate |
| AR012871A1 (es) * | 1997-05-29 | 2000-11-22 | Novartis Ag | 2-amino-7-(2-hidroxietilo-1-sustituido)-3,5-dihidropirrolo (3,2-d)pirimidin -4-onas, composiones farmaceuticas y el uso de las mismas para la manufacturade un medicamento. |
| US6355244B1 (en) | 1997-11-17 | 2002-03-12 | University Of Kentucky Research Foundation | Methods and compositions for the treatment of psoriasis |
| US6174888B1 (en) | 1998-05-28 | 2001-01-16 | Novartis Ag | 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-ones |
| GB0215392D0 (en) * | 2002-07-03 | 2002-08-14 | Glaxo Group Ltd | Chemical compounds |
| CA2536887C (en) * | 2003-08-26 | 2012-03-06 | Teijin Pharma Limited | Pyrrolopyrimidinone derivatives |
| US7557113B2 (en) | 2003-08-26 | 2009-07-07 | Teijin Pharma Limited | Substituted pyrrolo[3,2-d]pyrimidine derivatives |
| MY140748A (en) | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
| US7763257B2 (en) | 2004-12-09 | 2010-07-27 | Christina Juneau | Compositions comprising transforming growth factor (TGF)-β1 and TGF-β2 in admixture of proteins obtained from dairy products |
| WO2009079797A1 (en) | 2007-12-26 | 2009-07-02 | Critical Outcome Technologies, Inc. | Compounds and method for treatment of cancer |
| EP3023426A1 (en) | 2008-07-17 | 2016-05-25 | Critical Outcome Technologies, Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| WO2011120153A1 (en) | 2010-04-01 | 2011-10-06 | Critical Outcome Technologies Inc. | Compounds and method for treatment of hiv |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2866478B2 (ja) * | 1989-10-31 | 1999-03-08 | バイオクリスト・ファーマシューティカルズ・インコーポレイテッド | プリンヌクレオシドホスホリラーゼの阻害剤 |
| US5189039A (en) * | 1989-11-29 | 1993-02-23 | Biocryst, Inc. | 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the same |
-
1993
- 1993-03-25 CA CA002133346A patent/CA2133346A1/en not_active Abandoned
- 1993-03-25 AU AU42766/93A patent/AU4276693A/en not_active Abandoned
- 1993-03-25 EP EP93912081A patent/EP0638080A4/en not_active Withdrawn
- 1993-03-25 WO PCT/US1993/002841 patent/WO1993021187A1/en not_active Ceased
- 1993-03-25 KR KR1019940703788A patent/KR950701335A/ko not_active Ceased
- 1993-03-25 FI FI944933A patent/FI944933A0/fi not_active Application Discontinuation
- 1993-03-25 JP JP5518357A patent/JPH07507062A/ja active Pending
- 1993-03-25 HU HU9403021A patent/HUT71559A/hu unknown
- 1993-03-25 RU RU94046387/04A patent/RU94046387A/ru unknown
-
1994
- 1994-10-20 NO NO943988A patent/NO303637B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO943988L (no) | 1994-10-20 |
| EP0638080A4 (en) | 1995-08-23 |
| KR950701335A (ko) | 1995-03-23 |
| RU94046387A (ru) | 1996-09-27 |
| HU9403021D0 (en) | 1994-12-28 |
| CA2133346A1 (en) | 1993-10-28 |
| WO1993021187A1 (en) | 1993-10-28 |
| FI944933L (fi) | 1994-10-20 |
| FI944933A7 (fi) | 1994-10-20 |
| NO943988D0 (no) | 1994-10-20 |
| JPH07507062A (ja) | 1995-08-03 |
| HUT71559A (en) | 1995-12-28 |
| AU4276693A (en) | 1993-11-18 |
| EP0638080A1 (en) | 1995-02-15 |
| FI944933A0 (fi) | 1994-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO308533B1 (no) | Heteroarylaminer, anvendelse derav og farmasøytisk preparat | |
| DK1023900T3 (da) | Farmaceutisk præparat indeholdende S-nitroso-lipoproteiner og anvendelse deraf | |
| BR1100824A (pt) | Composto e composição farmacêutica | |
| NO943511D0 (no) | Farmasöytiske preparater og anvendelse derav | |
| NO307707B1 (no) | Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav | |
| FI944832A7 (fi) | Farmaseuttinen koostumus | |
| FI945281L (fi) | Heterosykliset yhdisteet, niiden valmistus ja käyttö | |
| NO307092B1 (no) | Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding | |
| DK0540609T3 (da) | Cephalosporiner og homologer, fremstillinger og farmaceutiske præparater | |
| NO303637B1 (no) | 7-disubstituert-metyl-4-okso-3H,5H-pyrrolo-£3,2-d|pyrimidin, farmas°ytisk preparat, og anvendelse derav | |
| ITMI932540A0 (it) | Composizione farmaceutica | |
| NO953673D0 (no) | [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse | |
| FI954229L (fi) | Heterosykliset yhdisteet, niiden käyttö ja valmistus | |
| DE69413111D1 (de) | Shampoozusammensetzung | |
| DE69430362D1 (de) | Ektoparasitizide formulierung | |
| DK0492667T3 (da) | 1,4-Benzothiazin-2-eddikesyrederivater, fremgangsmåder til fremstilling deraf og anvendelse deraf | |
| LV10579A (lv) | Farmaceitiska kompozicija | |
| FI921456A7 (fi) | Substituoituja 2',3'-didesoksi-5-trifluorimetyyliuridiineja, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa | |
| NO943236D0 (no) | Nye 1,2-ditiol-3-tionderivater og farmasöytisk preparat inneholdende disse | |
| NO911298D0 (no) | Farmasoeytisk preparat og anvendelse derav. | |
| ITMI932019A0 (it) | Composizione farmaceutica antivirale contenente la 2-ammino 4,6-dicloropirimidina e metisoprinolo | |
| NO179907C (no) | Benzokinoksaliner og farmasöytiske preparater inneholdende de samme | |
| BR1100293A (pt) | Composto e composição farmacêutica | |
| BR1100809A (pt) | Composto e composição farmacêutica | |
| BR1100486A (pt) | Composto e composição farmacêutica |